Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Synopsys, Inc. ("Synopsys" or the "Company") and reminds investors of the December 30, 2025 ...
The Gross Law Firm issues the following notice to shareholders of Synopsys, Inc. . Shareholders who purchased shares of SNPS during ...
Zacks Investment Research on MSN
Is it worth investing in Synopsys (SNPS) based on Wall Street's bullish views?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a ...
Synopsys is rated Hold with a $475 price target, reflecting a 10% upside and market-like performance amid premium valuation ...
Fintel reports that on December 3, 2025, Keybanc maintained coverage of Synopsys (NasdaqGS:SNPS) with a Overweight ...
This investment serves a strategic purpose, aimed at enhancing the existing partnership between the two firms to advance ...
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers and acquirers of Synopsys, Inc. (NASDAQ: SNPS) securities between December 4, 2024 and September 9, 2025, both dates ...
Synopsys stock ought to be on your radar. Here is why – it is presently trading in the support realm, levels from which it has bounced significantly before.
AI darling Nvidia announces a $2.0 billion stake in Synopsys Inc. Here's why that doesn't make SNPS shares worth owning for ...
Worries about regulatory headwinds weighed on vaccine producers on Monday, Dec. 1, 2025, while a chip design software maker got a boost from a partnership with an AI darling.
P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback